drugset / Trial / NCT00674206
A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate if the combination of gemcitabine and oxaliplatin is effective for triple negative breast cancer.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-08
- Completion
- 2009-10
Outcome
Outcome not reported
Stopped (Business): “Sponsor funding stopped”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | — |
| Subject | Oxaliplatin | Small molecule | 100 mg/m2 | Intravenous |